Mast cells express IL‐13Rα1: IL‐13 promotes human lung mast cell proliferation and FcɛRI expression
Abstract
Background: The Th2 cytokine interleukin (IL)‐13 is implicated in the development of various allergic diseases including asthma. The IL‐13 receptor, IL‐13Rα1, is expressed on most leukocytes, except T‐cells. Evidence to support IL‐13Rα1 expression on mast cells is limited.Methods: We investigated: (i) IL‐13Rα1 expression by human lung mast cells (HLMC); (ii) the number of IL‐13Rα1+ bronchial submucosal mast cells in subjects with asthma and normal controls and (iii) the effect of IL‐13 priming on HLMC expression of high‐affinity IgE receptor (FcɛRI), stem cell factor receptor (CD117), histamine release, proliferation, and survival.Results: Human lung mast cell expressed IL‐13Rα1 mRNA. IL‐13Rα1 was highly expressed on the surface HLMC (82 ± 9%). Bronchial submucosal mast cell IL‐13Rα1 expression was higher in asthmatics (86 ± 2%) than normal controls (78 ± 2%; P = 0.015). IL‐13 priming for 30 min did not increase HLMC histamine release, in the presence or absence of SCF or in response to IgE/anti‐IgE activation. IL‐13 priming for 5 days upregulated HLMC FcɛRI expression (22% increase in fluorescent intensity; P = 0.003), increased histamine release following IgE/anti‐IgE activation by 56% (P = 0.03) and increased proliferation by 50% (P = 0.003) without affecting cell survival or CD117 expression. The IL‐13 specific neutralizing antibody CAT‐354 inhibited all IL‐13 mediated effects.Conclusion: Human lung mast cell express IL‐13Rα1 and activation by IL‐13 for 5 days increased FcɛRI expression and proliferation. Histamine release was not affected by short‐term priming with IL‐13, but was upregulated by priming for 5 days suggesting that this effect was mediated by the increased FcɛRI expression. These data support the view that targeting IL‐13 may be beneficial in the treatment of asthma.Keywords
This publication has 31 references indexed in Scilit:
- Synergistic effect of SCF and TNF-α on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cellsJournal of Leukocyte Biology, 2005
- High-resolution tracking of cell division demonstrates differential effects of TH1 and TH2 cytokines on SCF-dependent human mast cell production in vitro:correlation with apoptosis and Kit expressionBlood, 2005
- Interleukin‐13 in asthma pathogenesisImmunological Reviews, 2004
- STAT-1 is activated by IL-4 and IL-13 in multiple cell typesMolecular Immunology, 2004
- Molecular cloning of canine IL-13 receptor α chain (α1 and α2) cDNAs and detection of corresponding mRNAs in canine tissuesVeterinary Immunology and Immunopathology, 2001
- IgE regulation and roles in asthma pathogenesisJournal of Allergy and Clinical Immunology, 2001
- Activated mast cells produce interleukin 13.Journal of Experimental Medicine, 1995
- Effects of interleukin (IL)‐13 on immediate‐early response gene expression, phenotype and differentiation of human mast cells. Comparison with IL‐4European Journal of Immunology, 1995
- Phenotypic Characterization of the Human Mast‐Cell Line HMC‐1Scandinavian Journal of Immunology, 1994
- Immunohistochemistry on Resin Sections: A Comparison of Resin Embedding Techniques for Small Mucosal BiopsiesBiotechnic & Histochemistry, 1993